Also found in: Medical, Encyclopedia, Wikipedia.


 (bī′ō-prŏs′ĕs, -prō′sĕs)
1. A technique that produces a biological material, such as a genetically engineered microbial strain, for commercial use.
2. Production of a commercially useful chemical or fuel by a biological process, such as microbial fermentation or degradation.

bi′o·proc′ess v.


(ˌbaɪ oʊˈprɒs ɛs; esp. Brit. -ˈproʊ sɛs)
1. a method or procedure for preparing biological material for commercial use.
2. to treat or prepare through bioprocess.
References in periodicals archive ?
Hence, BRI mandated the Bioprocess Sector to give the biotechnology human resource agenda special priority and a separate focus.
For years the bioprocess industry has sought a method by which it could measure, in situ, multiple bioprocess assays continuously in real-time and utilize the resulting measurements for improved bioprocess management.
We are actively working to certify our other BioProcess manufacturing sites to the ISO 22301 standard including single use technologies, cell culture media and BioProcess hardware.
The Finesse product platform includes an extensive portfolio of novel disposable sensors, modular configure-to-order automation hardware, and intelligent software that can harmonize global bioprocess information and technology transfer.
has launched an online MAb (monoclonal antibody) Bioprocess Sizing Tool to help biomanufacturing scientists and engineers develop and design filtration and chromatography processes.
M2 EQUITYBITES-17 February 2010-BAC extends collaboration with GE Healthcare with addition of new bioprocess affinity chromatography ligand(C)2010 M2 COMMUNICATIONS http://www.
This welcome new edition covers bioprocess engineering principles for the reader with a limited engineering background.
Emmanuel Ligner, Global Commercial Manager, BioProcess, GE Healthcare Life Sciences, said: Healthcare providers and the biopharmaceutical industry are facing enormous pressures.
Bioprocess Bag Management Systems support the usage and handling of flexible containers for bulk intermediate reagents and solutions.
Impeller stirred-tank bioreactors, currently used for hiPSC bioprocessing, impose detrimental stresses on cultured hiPSCs, resulting in heterogeneity of cells and cell-aggregates, limited bioprocess reproducibility, and low hiPSC expansion efficiency at high costs.
A: To prevent cross contamination in stainless steel processing equipment, bioprocess engineers must develop and validate clean-in-place (CIP) procedures that remove all residual proteins between processes.